RIGL
RIGEL PHARMACEUTICALS INCCompany Information
- Company Name
- RIGEL PHARMACEUTICALS INC
- CIK
- CIK0001034842
- Category
- Accelerated filer
- Ticker: Exchange
- RIGL: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- RIGL
SEC filing data through
Insider Sentiment
- Last purchase
- —
- Last sale
- 2026-06-22
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 9,000
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 15,120,186
- Shares outstanding
- 18,541,000
- Ownership
- 81.55%
Earnings Market Reaction
- Filing date
- 2026-08-04
- Price on filing date
- —
- 1-month reaction
- 20.10%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 61 | 24 | 41 | 49 | 53 | 46 | 57 | 52 | 36 | 26 | 33 | 45 | ||||||
| Short Term Investments | 35 | 122 | 114 | 89 | 55 | 31 | 21 | 9 | 13 | 24 | 24 | 17 | ||||||
| Accounts Receivable Net Current | 56 | 50 | 52 | 46 | 40 | 42 | 42 | 31 | 29 | 28 | 31 | 24 | ||||||
| Inventory Net | 14 | 12 | 12 | 13 | 10 | 5 | 6 | 5 | 8 | 7 | 6 | 6 | ||||||
| Prepaid Expense And Other Assets Current | 20 | 26 | 22 | 19 | 17 | 23 | 10 | 10 | 9 | 9 | 6 | 3 | ||||||
| Assets Current | 186 | 234 | 240 | 215 | 175 | 147 | 135 | 106 | 95 | 92 | 99 | 95 | ||||||
| Intangible Assets Net Including Goodwill | 94 | 24 | 25 | 25 | 26 | 27 | 27 | 28 | 28 | 29 | 14 | 14 | ||||||
| Property Plant And Equipment Net | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Deferred Income Tax Assets Net | 238 | 243 | 246 | - | - | - | 0 | - | - | - | - | - | ||||||
| Operating Lease Right Of Use Asset | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | ||||||
| Other Assets Noncurrent | 3 | 2 | 2 | 1 | 4 | 2 | 2 | 5 | 5 | 4 | 3 | 5 | ||||||
| Assets | 521 | 505 | 514 | 243 | 207 | 176 | 164 | 139 | 128 | 127 | 117 | 115 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 4 | 4 | 7 | 4 | 7 | 4 | 3 | 4 | 6 | 9 | 7 | 8 | ||||||
| Employee Related Liabilities Current | 9 | 6 | 12 | 10 | 8 | 6 | 10 | 8 | 6 | 5 | 9 | 8 | ||||||
| Asset Acquisition Contingent Consideration Liability Current | 0 | 5 | 5 | 5 | 5 | - | 0 | 5 | 15 | 15 | - | - | ||||||
| Contract With Customer Refund Liability Current | 28 | 28 | 28 | 30 | 30 | 28 | 26 | 22 | 19 | 16 | 16 | 15 | ||||||
| Loans Payable Current | 39 | 30 | 30 | 30 | 22 | 15 | 7 | - | - | 15 | 7 | - | ||||||
| Other Accrued Liabilities Current | 8 | 10 | 11 | 9 | 9 | 7 | 12 | 10 | 6 | 5 | 5 | 5 | ||||||
| Contract With Customer Liability Current | - | - | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Other Liabilities Current | - | - | 11 | - | - | - | 12 | - | - | 1 | 4 | 5 | ||||||
| Operating Lease Liability Current | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | ||||||
| Liabilities Current | 96 | 89 | 99 | 94 | 87 | 67 | 63 | 54 | 59 | 73 | 53 | 48 | ||||||
| Asset Acquisition Contingent Consideration Liability Noncurrent | - | - | 0 | - | - | 5 | 5 | - | - | - | - | - | ||||||
| Operating Lease Liability Noncurrent | 0 | 0 | 0 | 1 | 1 | 1 | 0 | - | - | 0 | 0 | 0 | ||||||
| Long Term Loans Payable | 0 | 15 | 22 | 30 | 37 | 45 | 52 | 60 | 60 | 45 | 52 | 60 | ||||||
| Other Liabilities Noncurrent | - | - | 0 | - | - | 40 | 40 | 40 | 40 | 40 | 40 | 39 | ||||||
| Liabilities | 96 | 105 | 122 | 125 | 125 | 157 | 161 | 154 | 158 | 158 | 146 | 147 | ||||||
Stockholders Equity | ||||||||||||||||||
| Preferred Stock Value | - | - | 0 | - | - | - | 0 | - | - | - | - | - | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital Common Stock | 1,423 | 1,414 | 1,414 | 1,409 | 1,401 | 1,397 | 1,393 | 1,390 | 1,387 | 1,384 | 1,379 | 1,376 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -0 | -0 | 0 | 0 | 0 | -0 | 0 | 0 | -0 | -0 | 0 | -0 | ||||||
| Retained Earnings Accumulated Deficit | -997 | -1,014 | -1,023 | -1,291 | -1,319 | -1,379 | -1,390 | -1,404 | -1,417 | -1,416 | -1,408 | -1,408 | ||||||
| Stockholders Equity | 425 | 400 | 391 | 118 | 82 | 19 | 3 | -15 | -30 | -32 | -29 | -32 | ||||||
| Liabilities And Stockholders Equity | 521 | 505 | 514 | 243 | 207 | 176 | 164 | 139 | 128 | 127 | 117 | 115 | ||||||
| Stockholders Equity Note Stock Split Conversion Ratio1 | - | - | - | - | - | - | - | - | 0 | - | - | - | ||||||
| Preferred Stock Par Or Stated Value Per Share | - | - | 0.00 | - | - | - | 0.00 | - | - | - | 0.00 | - | ||||||
| Preferred Stock Shares Authorized | - | - | 10 | - | - | - | 10 | - | - | - | 10 | - | ||||||
| Preferred Stock Shares Issued | - | - | 0 | - | - | - | 0 | - | - | - | 0 | - | ||||||
| Preferred Stock Shares Outstanding | - | - | 0 | - | - | - | 0 | - | - | - | 0 | - | ||||||
| Common Stock Par Or Stated Value Per Share | - | - | 0.00 | - | - | - | 0.00 | - | - | - | 0.00 | - | ||||||
| Common Stock Shares Authorized | - | - | 400 | - | - | - | 400 | - | - | - | 400 | - | ||||||
| Common Stock Shares Issued | - | - | 18 | - | - | - | 18 | - | - | - | 17 | - | ||||||
| Shares Outstanding | - | - | 18 | - | - | - | 18 | - | - | - | 17 | - | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialRIGEL PHARMACEUTICALS INC (RIGL) — SEC Financial Statements & Analysis
RIGEL PHARMACEUTICALS INC (RIGL) is a pharmaceutical preparations company, incorporated in DE. RIGEL PHARMACEUTICALS INC trades on Nasdaq as: RIGL. RIGEL PHARMACEUTICALS INC (RIGL)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-04. Based on that filing, RIGEL PHARMACEUTICALS INC carries a market cap of $725.32M, a P/E ratio of 2.25x, a P/B ratio of 1.70x, a P/S ratio of 2.67x, an enterprise value of $703.69M, and an EV/EBITDA multiple of 7.84x. On profitability, it posts a gross margin of 91.21%, an operating margin of 32.09%, a net margin of 118.65%, a Return on Equity (ROE) of 126.90%, a Return on Assets (ROA) of 88.46%, and a Return on Invested Capital (ROIC) of 37.45%. Per share, it reports EPS of $17.36, diluted EPS of $16.45, free cash flow per share of $0.49, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 11.13% year-over-year, net income growth of 229.08% year-over-year, and EPS growth of 217.44% year-over-year. On the balance sheet, it maintains a current ratio of 1.94x, a quick ratio of 1.58x, working capital of $89.94M, a debt-to-equity ratio of 0.22x, a debt ratio of 0.18, an interest coverage ratio of 21.20x, free cash flow of $9.04M (TTM), and net debt of $-21.64M. Figures sourced from SEC EDGAR.
- Market Cap
- $725.32M
- P/E TTM
- 2.25x
- EPS TTM
- $17.36
- P/B TTM
- 1.70x
- ROE TTM
- 126.90%
- ROA TTM
- 88.46%
- Debt To Equity
- 0.22x
- Free Cash Flow TTM
- $9.04M
- Net Revenue TTM Growth 1Y
- 11.13%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is RIGEL PHARMACEUTICALS INC in?
RIGEL PHARMACEUTICALS INC (RIGL) operates in the Pharmaceutical Preparations industry.
What exchange does RIGL trade on?
RIGEL PHARMACEUTICALS INC (RIGL) trades on the Nasdaq.
Where is RIGEL PHARMACEUTICALS INC incorporated?
RIGEL PHARMACEUTICALS INC is incorporated in DE.
When was RIGEL PHARMACEUTICALS INC (RIGL)'s most recent SEC filing?
RIGEL PHARMACEUTICALS INC (RIGL)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-04.
What is RIGL's market cap?
RIGEL PHARMACEUTICALS INC (RIGL) has a market capitalization of $725.32M as of 2026-06-30.
What is RIGL's P/E ratio?
RIGEL PHARMACEUTICALS INC (RIGL)'s trailing twelve month P/E ratio is 2.25x as of 2026-06-30.
What is RIGL's EPS (earnings per share)?
RIGEL PHARMACEUTICALS INC (RIGL)'s trailing twelve month EPS is $17.36 as of 2026-06-30.
What is RIGL's ROE (return on equity)?
RIGEL PHARMACEUTICALS INC (RIGL)'s trailing twelve month Return on Equity (ROE) is 126.90% as of 2026-06-30.
What is RIGL's ROA (return on assets)?
RIGEL PHARMACEUTICALS INC (RIGL)'s trailing twelve month Return on Assets (ROA) is 88.46% as of 2026-06-30.
What is RIGL's ROIC (return on invested capital)?
RIGEL PHARMACEUTICALS INC (RIGL)'s trailing twelve month Return on Invested Capital (ROIC) is 37.45% as of 2026-06-30.
What is RIGL's EV/EBITDA?
RIGEL PHARMACEUTICALS INC (RIGL)'s trailing twelve month EV/EBITDA is 7.84x as of 2026-06-30.